TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Class A Common Stock
Shares
−11.91K
Price / share
$4.25
Trade value
$50.61K
% of position
Net shares
−11.91K
Net value
-$50.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 5/15/2025 | F · Tax Withholding | −11.91K | $4.25 | $50.61K | 1.4% | 842.10K | 830.19K |
| Total | −11.91K | -$50.61K | ||||||
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
92.75K
Exercise price
0.06
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
740.69K
Exercise price
6.09
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
70.04K
Exercise price
7.25
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
289.84K
Exercise price
0.04
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
0.00
Shares owned
81.15K
Exercise price
0.14
Expiration
—
Exercise window
—
Underlying
0.00
Owned
1.27M
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock | 0.06 | — | — | 0.00 | 92.75K |
| Stock Option (Right to Buy) Direct | Class A Common Stock | 6.09 | — | — | 0.00 | 740.69K |
| Stock Option (Right to Buy) Direct | Class A Common Stock | 7.25 | — | — | 0.00 | 70.04K |
| Stock Option (Right to Buy) Direct | Class A Common Stock | 0.04 | — | — | 0.00 | 289.84K |
| Stock Option (Right to Buy) Direct | Class A Common Stock | 0.14 | — | — | 0.00 | 81.15K |
| Total | 0.00 | 1.27M | ||||